Carlos A Guzman Selected Research

S- (2,3- bispalmitoyloxypropyl)- cysteinyl- amido- monomethoxyl polyethylene glycol

10/2014

Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos A Guzman Research Topics

Disease

15	Infections 01/2022 - 12/2004
3	Neoplasms (Cancer) 01/2017 - 01/2009
2	Inflammation (Inflammations) 01/2022 - 01/2010
2	Communicable Diseases (Infectious Diseases) 03/2021 - 07/2014
2	Human Influenza (Influenza) 10/2017 - 07/2011
2	Virus Diseases (Viral Diseases) 01/2017 - 07/2007
2	Cystic Fibrosis (Mucoviscidosis) 09/2015 - 01/2015
2	Tuberculosis (Tuberculoses) 04/2009 - 10/2008
2	Typhoid Fever (Typhoid) 05/2006 - 12/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2020
1	Persistent Infection 01/2020
1	Viremia 01/2020
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 01/2017
1	Reinfection 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Diabetes Mellitus 01/2017
1	Obesity 01/2017
1	Myocardial Infarction 01/2017
1	Polyploidy 09/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Migraine Disorders (Migraine) 01/2016
1	Tetanus 02/2015
1	Measles 02/2015
1	Whooping Cough (Pertussis) 02/2015
1	Diphtheria 02/2015
1	Influenza in Birds (Avian Flu) 01/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2010
1	Streptococcal Infections (Streptococcal Infection) 09/2010
1	Sepsis (Septicemia) 09/2010
1	Salmonella Infections (Salmonellosis) 12/2004
1	Hemolysis 09/2003
1	Starvation 12/2002

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 03/2021 - 12/2004
6	AntigensIBA 01/2020 - 07/2007
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2015 - 12/2004
2	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2014
2	InterferonsIBA 01/2022 - 01/2010
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
2	LipidsIBA 01/2017 - 10/2008
2	LigandsIBA 10/2014 - 04/2009
1	EnzymesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	itaconic acidIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	entecavir FDA Link 01/2020
1	PerforinIBA 01/2019
1	IntegrinsIBA 01/2019
1	Protein Subunit VaccinesIBA 11/2017
1	OvalbuminIBA 10/2017
1	cyclic diadenosine phosphateIBA 10/2017
1	Peptides (Polypeptides)IBA 10/2017
1	CholesterolIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 09/2016
1	sortilinIBA 01/2016
1	FlunarizineIBA 01/2016
1	PhenothiazinesIBA 01/2016
1	Pimozide (Orap)FDA Link 01/2016
1	Granzymes (Granzyme)IBA 10/2015
1	LipopeptidesIBA 10/2014
1	Interleukin-4 (Interleukin 4)IBA 10/2014
1	S- (2,3- bispalmitoyloxypropyl)- cysteinyl- amido- monomethoxyl polyethylene glycolIBA 10/2014
1	Interleukin-10 (Interleukin 10)IBA 10/2014
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 07/2011
1	bis(3',5')-cyclic diguanylic acidIBA 07/2011
1	interleukin-21 (interleukin 21)IBA 10/2010
1	AntibodiesIBA 09/2010
1	CytokinesIBA 01/2010
1	Toll-Like Receptor 2IBA 01/2010
1	AllergensIBA 01/2010
1	Biological ProductsIBA 01/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2010
1	Immune Sera (Antisera)IBA 04/2009
1	Tumor Suppressor Protein p53IBA 01/2009
1	Arachidonic Acid (Vitamin F)IBA 10/2008
1	Eicosapentaenoic AcidIBA 10/2008
1	opacity factorIBA 03/2008
1	Neutralizing AntibodiesIBA 07/2007
1	Pharmaceutical PreparationsIBA 12/2004
1	LactoferrinIBA 09/2003
1	ProteomeIBA 12/2002

Therapy/Procedure

3	Therapeutics 03/2020 - 10/2015
1	Subcutaneous Injections 01/2020
1	Liver Transplantation 01/2017
1	Intranasal Administration 01/2010